Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
复制标题
DOI：
10.1186/1477-7517-10-13
复制
发表时间：
2013-08-19
影响因子：
4.4
通讯作者：
Parry C
中科院分区：
文献类型：
--
作者：
Petersen Z;Myers B;van Hout MC;Plüddemann A;Parry C
在撒哈拉以南非洲以外的全球艾滋病毒感染中，约有三分之一与注射吸毒有关，这在艾滋病毒感染者中所占比例越来越大。本文件是对监测艾滋病毒流行状况的需要作出的回应，因为它涉及到注射吸毒以及21个高流行率国家艾滋病毒治疗和减少伤害服务的可用性。设计了一份数据收集表，以涵盖关于注射吸毒者比率、艾滋病毒流行率和发病率的问题以及关于向注射吸毒者提供艾滋病毒治疗和减少伤害服务的信息。通过对文献的系统检索，从关键的信息提供者那里获得了以报告和期刊文章形式提供的关于艾滋病毒感染、注射吸毒的国家和区域数据。收到了11个国家填写的数据收集表。通过文献检索获得其他国家特定信息。在选定的国家中，艾滋病毒阳性的PWID的总体比例从哈萨克斯坦的3%到越南的58%不等。虽然注射吸毒在撒哈拉以南非洲相对罕见，但它是毛里求斯和肯尼亚艾滋病毒的主要驱动因素，分别约有47%和36%的PWID为艾滋病毒阳性。所有国家都向艾滋病患者提供抗逆转录病毒治疗，但服务覆盖率数据基本缺失。到2010年底，孟加拉国、印度和斯洛伐克的针头和注射器方案采用率达到了国际建议的每人200支注射器的目标，而哈萨克斯坦、越南和塔吉克斯坦的采用率达到了每人100至200支注射器。接受阿片类药物替代疗法的PWID比例从哈萨克斯坦的0.1%到毛里求斯的32.8%不等，大多数国家的覆盖率不到3%。为了能够监测艾滋病毒治疗和减少对艾滋病感染者危害的服务对这一流行病的影响，需要使用标准化指标定期收集关于注射吸毒者和减少对艾滋病感染者危害的服务的流行病学数据。
About a third of the global HIV infections outside sub-Saharan Africa are related to injecting drug use (IDU), and this accounts for a growing proportion of persons living with HIV. This paper is a response to the need to monitor the state of the HIV epidemic as it relates to IDU and the availability of HIV treatment and harm reduction services in 21 high epidemic countries. A data collection form was designed to cover questions on rates of IDU, prevalence and incidence of HIV and information on HIV treatment and harm reduction services available to people who inject drugs (PWID). National and regional data on HIV infection, IDU in the form of reports and journal articles were sought from key informants in conjunction with a systematic search of the literature. Completed data collection forms were received for 11 countries. Additional country-specific information was sourced via the literature search. The overall proportion of HIV positive PWID in the selected countries ranged from 3% in Kazakhstan to 58% in Vietnam. While IDU is relatively rare in sub-Saharan Africa, it is the main driver of HIV in Mauritius and Kenya, with roughly 47% and 36% of PWID respectively being HIV positive. All countries had antiretroviral treatment (ART) available to PWID, but data on service coverage were mainly missing. By the end of 2010, uptake of needle and syringe programmes (NSP) in Bangladesh, India and Slovakia reached the internationally recommended target of 200 syringes per person, while uptake in Kazakhstan, Vietnam and Tajikistan reached between 100-200 syringes per person. The proportion of PWID receiving opioid substitution therapy (OST) ranged from 0.1% in Kazakhstan to 32.8% in Mauritius, with coverage of less than 3% for most countries. In order to be able to monitor the impact of HIV treatment and harm reduction services for PWID on the epidemic, epidemiological data on IDU and harm reduction service provision to PWID needs to be regularly collected using standardised indicators.
登录
查看更多内容
DOI：
10.1136/bmj.b1649
发表时间：
2009-04-30
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Wood E;Kerr T;Marshall BD;Li K;Zhang R;Hogg RS;Harrigan PR;Montaner JS
通讯作者：
Montaner JS
影响因子：
168.9
作者：
Montaner, Julio S. G.;Lima, Viviane D.;Barrios, Rolando;Yip, Benita;Wood, Evan;Kerr, Thomas;Shannon, Kate;Harrigan, P. Richard;Hogg, Robert S.;Daly, Patricia;Kendall, Peny
通讯作者：
Kendall, Peny
影响因子：
168.9
作者：
Mathers, Bradley M.;Degenhardt, Louisa;Mattick, Richard P.
通讯作者：
Mattick, Richard P.
影响因子：
3.8
作者：
Bryant, Joanne;Topp, Libby;Maher, Lisa
通讯作者：
Maher, Lisa
影响因子：
168.9
作者：
Mathers, Bradley M.;Degenhardt, Louisa;Strathdee, Steffanie A.
通讯作者：
Strathdee, Steffanie A.